Works matching IS 00070963 AND DT 2024 AND VI 190 AND IP 4

Results: 52
    1

    Mycophenolate mofetil inhibits Merkel cell carcinoma growth.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 4, p. 593, doi. 10.1093/bjd/ljae018
    By:
    • Garman, Khalid A;
    • Thoreson, Nicholas;
    • Strong, Jennifer;
    • Hallaert, Patrick;
    • Gelb, Tara;
    • Shen, Min;
    • Hall, Matthew D;
    • Brownell, Isaac
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    For itch and insanity.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 4, p. 568, doi. 10.1093/bjd/ljad519
    By:
    • Cowper, Russ
    Publication type:
    Article
    29
    30

    Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 4, p. 549, doi. 10.1093/bjd/ljad459
    By:
    • Ewen, Tom;
    • Husain, Akhtar;
    • Stefanos, Niki;
    • Barrett, Paul;
    • Jones, Claire;
    • Ness, Tom;
    • Long, Anna;
    • Horswell, Stuart;
    • Bosomworth, Helen;
    • Lowenstein, Joe;
    • Richardson, Grant;
    • Swan, David;
    • McConnell, Ashleigh;
    • Rose, Aidan;
    • Andrew, Tom;
    • Reynolds, Nick;
    • Malvehy, Josep;
    • Carrera, Christina;
    • Alos, Llucia;
    • Mailer, Sonia
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 4, p. 578, doi. 10.1093/bjd/ljad495
    By:
    • Moscarella, Elvira;
    • Di Brizzi, Eugenia Veronica;
    • Alpi, Paolo;
    • Arcelli, Alessandra;
    • Badellino, Serena;
    • Bossi, Paolo;
    • Calzavara-Pinton, Pier Giacomo;
    • Di Stefani, Alessandro;
    • Dika, Emi;
    • Eibenschutz, Laura;
    • Fargnoli, Maria Concetta;
    • Fionda, Bruno;
    • Gravina, Giovanni Luca;
    • Leonulli, Barbara Grilli;
    • Longo, Caterina;
    • Lospalluti, Lucia;
    • Nardone, Valerio;
    • Pimpinelli, Nicola;
    • Quaglino, Pietro;
    • Queirolo, Paola
    Publication type:
    Article
    38
    39
    40
    41

    Evaluating bimekizumab safety.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 4, p. 458, doi. 10.1093/bjd/ljad451
    By:
    • Lovell, Katie;
    • Feldman, Steven R
    Publication type:
    Article
    42

    Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 4, p. 559, doi. 10.1093/bjd/ljad430
    By:
    • Abhishek, Abhishek;
    • Stevenson, Matthew D;
    • Nakafero, Georgina;
    • Grainge, Matthew J;
    • Evans, Ian;
    • Alabas, Oras;
    • Card, Tim;
    • Taal, Maarten W;
    • Aithal, Guruprasad P;
    • Fox, Christopher P;
    • Mallen, Christian D;
    • Windt, Danielle A van der;
    • Riley, Richard D;
    • Warren, Richard B;
    • Williams, Hywel C
    Publication type:
    Article
    43
    44

    Global consensus process to establish a core dataset for hidradenitis suppurativa registries.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 4, p. 510, doi. 10.1093/bjd/ljad454
    By:
    • Wainman, Hannah E;
    • Chandran, Nisha S;
    • Frew, John W;
    • Garg, Amit;
    • Gibbons, Angela;
    • Gierbolini, Athena;
    • Horvath, Barbara;
    • Jemec, Gregor B;
    • Kirby, Brian;
    • Kirby, Joselyn;
    • Lowes, Michelle A;
    • Martorell, Antonio;
    • McGrath, Barry M;
    • Naik, Haley B;
    • Oon, Hazel H;
    • Prens, Errol;
    • Sayed, Christopher J;
    • Thorlacius, Linnea;
    • Zee, Hessel H Van der;
    • Villumsen, Bente
    Publication type:
    Article
    45
    46

    Formylpeptide receptor 1 contributes to epidermal barrier dysfunction-induced skin inflammation through NOD-like receptor C4-dependent keratinocyte activation.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 4, p. 536, doi. 10.1093/bjd/ljad455
    By:
    • Shao, Shuai;
    • Sun, Zhongbin;
    • Chu, Mengyang;
    • Chen, Jiaoling;
    • Cao, Tianyu;
    • Swindell, William R;
    • Bai, Yaxing;
    • Li, Qingyang;
    • Ma, Jingyi;
    • Zhu, Zhenlai;
    • Schuler, Andrew;
    • Helfrich, Yolanda;
    • Billi, Allison C;
    • Li, Zhiguo;
    • Hao, Junfeng;
    • Xiao, Chunying;
    • Dang, Erle;
    • Gudjonsson, Johann E;
    • Wang, Gang
    Publication type:
    Article
    47
    48
    49
    50